Time in Range
7
0
0
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
14%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Evaluating an Insulin Pump for Time in Range (TIR) in Patients with Type 1 Diabetes
Feasibility of DPP-4 Inhibitor Therapy on Advanced Hybrid Closed Loop System
Real Time Continuous Glucose Monitoring System in T2DM With Pregnacy
Insulin Dose Calculation Software in Insulin Therapy
Comparison of Safety and Efficacy of Needle-Free Injector and Insulin Pen in Patients With T2DM
Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T1DM
The Use of Faster Acting Aspart in Type 1 Diabetes Patients